Tiludronate

Known as: (chloro-4-phenyl)thiomethylene biphosphonate, (chloro-4-phenyl)thiomethylene bisphosphonate 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
INTRODUCTION The aim of this prospective, randomized, controlled, double-blind study was to evaluate the effects of tiludronate… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Review
1999
Review
1999
Bisphosphonates (BPs) used as inhibitors of bone resorption all contain two phosphonate groups attached to a single carbon atom… (More)
Is this relevant?
1999
1999
The disposition of tiludronate in mouse, rat, rabbit, dog and monkey has been studied after oral and intravenous doses. Like… (More)
Is this relevant?
1997
1997
Signaling pathways mediated by tyrosine phosphorylation and dephosphorylation have been reported to be involved in the regulation… (More)
Is this relevant?
1996
1996
Although bisphosphonates have been shown to be potent inhibitors of osteoclast-mediated bone resorption in vivo and in vitro and… (More)
Is this relevant?
1995
1995
A double-blind, randomized, placebo-controlled study was performed to evaluate the effect of oral tiludronate therapy in 139… (More)
Is this relevant?
1995
1995
Immobilization secondary to spinal cord injury is associated with a marked and rapid atrophy of trabecular bone (disuse… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
The mechanism of action of tiludronate [(4-chlorophenyl)-thiomethylene bisphosphonate] on osteoclastic bone resorption was… (More)
Is this relevant?
1991
1991
Tiludronate is a new bisphosphonate whose efficacy has already been reported for the prevention of postmenopausal bone loss. We… (More)
Is this relevant?
1989
1989
76 healthy women, who had been menopausal for less than 96 months and who had never received any form of treatment to prevent… (More)
Is this relevant?